Songlin Song

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinoma.

Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinoma.

Journal: Journal of nanobiotechnology

Published: February 06, 2026

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Journal: Cancers

Published: November 28, 2025

One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization.

One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization.

Journal: Archivos de bronconeumologia

Published: November 04, 2025

The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective study.

The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective study.

Journal: Cardiovascular diagnosis and therapy

Published: December 30, 2024

FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy.

FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy.

Journal: BMC cancer

Published: October 25, 2024

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: August 20, 2024

Prospective Comparison of Conventional CTA With Angiography-CT for Identification of Culprit Systemic Arteries in Patients Undergoing Bronchial Artery Embolization for Hemoptysis.

Prospective Comparison of Conventional CTA With Angiography-CT for Identification of Culprit Systemic Arteries in Patients Undergoing Bronchial Artery Embolization for Hemoptysis.

Journal: AJR. American journal of roentgenology

Published: August 14, 2024

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience.

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience.

Journal: Frontiers in immunology

Published: August 01, 2024

Optimal timing for TIPS and PSE combination treatment in patients with cirrhosis-related variceal bleeding and hypersplenism.

Optimal timing for TIPS and PSE combination treatment in patients with cirrhosis-related variceal bleeding and hypersplenism.

Journal: Academic radiology

Published: July 23, 2024

Hepatic arterial infusion chemotherapy combined with toripalimab and surufatinib for the treatment of advanced intrahepatic cholangiocarcinoma.

Hepatic arterial infusion chemotherapy combined with toripalimab and surufatinib for the treatment of advanced intrahepatic cholangiocarcinoma.

Journal: Diagnostic and interventional radiology (Ankara, Turkey)

Published: June 05, 2024

Recent advances in hepatocellular carcinoma-targeted nanoparticles.

Recent advances in hepatocellular carcinoma-targeted nanoparticles.

Journal: Biomedical materials (Bristol, England)

Published: February 03, 2024

Effect of probiotics and fecal microbiota transplantation in dirty rats with established primary liver cancer.

Effect of probiotics and fecal microbiota transplantation in dirty rats with established primary liver cancer.

Journal: Future microbiology

Published: November 07, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026